Gastrointestinal infections from Clostridioides difficile (C. diff) affect about 500,000 people in the U.S. a year, 20,000 of which die. Now, a new study performed in mice may have found a solution for the condition.

Each year, about 500,000 people in the U.S. deal with gastrointestinal infections from Clostridioides difficile (C. diff), and more than 20,000 die from these infections. A new study performed in mice has identified a compound that prevented C. diff infection caused by multiple strains of the bacterium, including those that cause serious illness. Researchers are now using this compound to develop new drug candidates that might eventually offer a way to prevent serious C. diff infections in people.

Even though you can't see them, your home is full of microscopic germs that can make your family or visitors sick. "Even the cleanest home has bacteria and viruses," says Ernesto Abel-Santos, a professor of biochemistry at the University of Nevada, Las Vegas. "In fact, most have benefits for us."

UNLV researchers are part of a team that will receive nearly $3 million in federal funding for a project focusing on the nuclear energy workforce.

Biology student Citlally Lopez wants to help medical patients every step of the way.

Citlally López has two clear goals: to find a cure for cancer , through her new research grant , and to break down the cultural and gender barriers that surround the very masculine world of science .

Citlally López has two clear goals: to find a cure for cancer and to break the cultural and gender barriers that surround the very masculine world of science.

Organic chemistry undergraduate Citlally Lopez strives to diversify science.

Don’t let viruses and bacteria spread or make your family sick.

UNLV student Citlally Lopez is breaking barriers and making waves in the world of science.

A UNLV undergrad is on a quest to cure cancer.

An inspiring story for new generations.